Patents Assigned to Rilento Pharma, LLC
  • Patent number: 12433879
    Abstract: A malleable sustained release formulation is created utilizing a local anesthetic wherein the composition is made sustained release by incorporating it into a bovine or porcine hemostatic agent. The composition is malleable enough to fit into a cavity such as a dental cavity and form the shape of the cavity. In addition to providing sustained release of the anesthetic, the composition also provides quicker reduction in bleeding.
    Type: Grant
    Filed: May 1, 2024
    Date of Patent: October 7, 2025
    Assignee: Rilento Pharma, LLC
    Inventor: Khashayar Kevin Neshat
  • Patent number: 12324858
    Abstract: A sustained release pharmaceutical formulation for pain management comprises an active ingredient, and a water-miscible and hygroscopic network-forming material, the active ingredient being dispersed within the water-miscible and hygroscopic network-forming material. The pharmaceutical may comprise a hydrophobic component, wherein the active ingredient dispersed within the water-miscible and hygroscopic network-forming material are together dispersed in hydrophobic component. Optionally, the pharmaceutical formulation may be combined with a reinforcing member for providing a system for sustained release of the pharmaceutical formulation for pain management.
    Type: Grant
    Filed: August 29, 2019
    Date of Patent: June 10, 2025
    Assignee: Rilento Pharma, LLC
    Inventors: Khashayar Kevin Neshat, William Andrew Daunch, Anthony A. Parker, Mark Franklin Hanna, Raymond A. Dionne
  • Patent number: 11992482
    Abstract: A malleable sustained release formulation is created utilizing a local anesthetic wherein the composition is made sustained release by incorporating it into a bovine or porcine hemostatic agent. The composition is malleable enough to fit into a cavity such as a dental cavity and form the shape of the cavity. In addition to providing sustained release of the anesthetic, the composition also provides quicker reduction in bleeding.
    Type: Grant
    Filed: January 13, 2017
    Date of Patent: May 28, 2024
    Assignee: Rilento Pharma, LLC
    Inventor: Khashayar Kevin Neshat
  • Publication number: 20180169080
    Abstract: A malleable sustained release formulation is created utilizing a local anesthetic wherein the composition is made sustained release by incorporating it into a bovine or porcine hemostatic agent. The composition is malleable enough to fit into a cavity such as a dental cavity and form the shape of the cavity. In addition to providing sustained release of the anesthetic, the composition also provides quicker reduction in bleeding.
    Type: Application
    Filed: January 13, 2017
    Publication date: June 21, 2018
    Applicant: Rilento Pharma, LLC
    Inventor: Khashayar Kevin Neshat